Recent news and posts
New Order relating to cancer screening programs published in France
In January 2024, the Ministry of Health and Prevention published the Order in the Official Journal of the French Republic updating the cancer screening programs. The new Order replaces the previous one from September 2006 and specifies the implementation conditions for the organized screening programs for breast, colorectal, and cervical cancers.
The colorectal cancer screening program now offers a quantitative immunological test for blood in the stool to men and women aged 50 to 74 who have an average risk of developing colorectal cancer. The National Health Insurance Fund (CNAM) handles the procurement and management of the screening kits and the test analysis solution.
The cervical cancer screening program now involves a cytological examination for women aged 25 to 29 (a liquid-based sample is recommended for this examination) and an HPV-HR test for women aged 30 to 65. The National Papillomavirus Reference Center (CNRP) maintains a list of clinically validated HPV detection kits and cell collection media for primary cervical cancer screening.
Breast cancer screening is now offered every two years to people aged 50 to 74 and includes a clinical examination and a mammogram with two views per breast. Only facilities with digital mammography equipment can participate in the organized screening program.
See full details in French here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.